JAMP Pharma Corporation is voluntarily recalling one product lot of Atorvastatin tablets, 40 mg, 100-format (lot D10776B) at the retail level (type 1 recall).
On August 25, the company initiated with Health Canada a voluntary recall of PrJAMP-Atorvastatin 40mg 100-format tablets (lot D10776B) due to a possible mislabeling of certain bottles in the lot, which may be labeled as JAMP-Atorvastatin Calcium 10mg 500-format tablets (DIN 02504197), when they should be labeled as JAMP-Atorvastatin Calcium 40mg, 100-format tablets (DIN 02504219).
Atorvastatin is a prescription drug used to treat high cholesterol and other fats (such as triglycerides) in the blood to prevent cardiovascular diseases, some that can lead to heart attacks.